|low level resistance
Mar 28, 2007
1.Can a norvir/atanazavir/truvada regimen be successful in a treatment naive patient if there are mutations that cause low level resistance to Viread?
| Response from Dr. Young
Thanks for your post.
1) Yes, the regimen can be successful, but I have to wonder why one would select a tenofovir (Viread, part of Truvada)-based regimen in the presence of resistance. I'd look to other, fully potent nuke options if these were viable options-- the DHHS and IAS treatment guidelines point to the use of AZT/3TC (Combivir) or abacavir/3TC (Epzicom, Kivexa) as other options.
2) Yes, if there's significant resistance to nukes and non-nukes, there are treatment possibilities- definitely a regimen that included a ritonavir (Norvir)-boosted protease inhibitor, perhaps with a recycled nuke, T20 (Fuzeon) or one of the newer investigational drugs, such as maraviroc or raltegravir.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.